MeiraGTx is cashing in on a gene therapy that restored vision to 11 children who were born legally blind, licensing the ...

Emerging gene therapy administered through a one-time subretinal injection marks a major milestone for the inherited retinal disease ...

Effective management of inherited retinal diseases requires a comprehensive approach to diagnosis and treatment, according to ...

Coave Therapeutics unveils lead gene therapy program for retinal vascular diseases, powered by first-in-class vector for suprachoroidal delivery. CoTx-101 represents a potential b ...

PolyActiva and RareSight collaborate to create innovative therapies for rare pediatric retinal diseases, aiming to transform ...

After announcing earlier this week the appointment of Andreas Wallnöfer, PhD, MBA, to its Board of Directors, Optigo ...

The retina of the eye contains photoreceptor cells that convert light into neuronal signals, which ultimately allow us to see. The mammalian retina has a very limited ability to regenerate, and damage ...

SEATTLE -- A drug targeting senescent cells in diabetic macular edema (DME) and neovascular age-related macular degeneration (nAMD) produced mixed outcomes in two separate clinical trials. The 48-week ...

This activity is supported by independent medical education grants from 4D Molecular Therapeutics; Alkeus Pharmaceuticals, Inc.; Genentech, a member of the Roche ...

Embargoed for 9am CET (3am ET) on Monday November 3rdAmgen Ventures-backed AAVantgarde Bio has raised $143 million in series B funding that the Italian biotech will use to | Amgen Ventures-backed ...

Your eyes—retinal blood vessels and retinal imaging—may help predict heart disease, according to a new study. Here, doctors ...